ID NLGN3_HUMAN Reviewed; 848 AA. AC Q9NZ94; Q8NCD0; Q9NZ95; Q9NZ96; Q9NZ97; Q9P248; DT 23-MAY-2003, integrated into UniProtKB/Swiss-Prot. DT 23-MAY-2003, sequence version 2. DT 22-JUL-2008, entry version 62. DE RecName: Full=Neuroligin-3; DE AltName: Full=Gliotactin homolog; DE Flags: Precursor; GN Name=NLGN3; Synonyms=KIAA1480, NL3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2). RX MEDLINE=20231756; PubMed=10767552; DOI=10.1016/S0378-1119(00)00049-4; RA Philibert R.A., Winfield S.L., Sandhu H.K., Martin B.M., Ginns E.I.; RT "The structure and expression of the human neuroligin-3 gene."; RL Gene 246:303-310(2000). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 12-848. RC TISSUE=Brain; RX MEDLINE=20277482; PubMed=10819331; DOI=10.1093/dnares/7.2.143; RA Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. XVII. RT The complete sequences of 100 new cDNA clones from brain which code RT for large proteins in vitro."; RL DNA Res. 7:143-150(2000). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 410-848. RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP INTERACTION WITH DLG4. RX MEDLINE=97426629; PubMed=9278515; DOI=10.1126/science.277.5331.1511; RA Irie M., Hata Y., Takeuchi M., Ichtchenko K., Toyoda A., Hirao K., RA Takai Y., Rosahl T.W., Suedhof T.C.; RT "Binding of neuroligins to PSD-95."; RL Science 277:1511-1515(1997). RN [5] RP VARIANT AUTSX1/ASPGX1 CYS-451. RX MEDLINE=22608338; PubMed=12669065; DOI=10.1038/ng1136; RA Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., RA Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., RA Bourgeron T., Nyden A., Philippe A., Cohen D., Chabane N., RA Mouren-Simeoni M.C., Brice A., Sponheim E., Spurkland I., RA Skjeldal O.H., Coleman M., Pearl P.L., Cohen I.L., Tsiouris J., RA Zappella M., Menchetti G., Pompella A., Aschauer H., Van Maldergem L.; RT "Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 RT are associated with autism."; RL Nat. Genet. 34:27-29(2003). CC -!- FUNCTION: Neuronal cell surface protein thought to be involved in CC cell-cell-interactions by forming intercellular junctions through CC binding to beta-neurexins. May play a role in formation or CC maintenance of synaptic junctions. May also play a role in glia- CC glia or glia-neuron interactions in the developing peripheral CC nervous system. CC -!- SUBUNIT: Interacts with neurexin 1-beta, neurexin 2-beta and CC neurexin 3-beta (By similarity). Probably interacts through its C- CC terminus with DLG4/PSD-95 third PDZ domain. CC -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane CC protein (Potential). CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; Synonyms=HNL3s; CC IsoId=Q9NZ94-1; Sequence=Displayed; CC Name=2; Synonyms=HNL3; CC IsoId=Q9NZ94-2; Sequence=VSP_007534; CC -!- DISEASE: Defects in NLGN3 may be the cause of susceptibility to X- CC linked autism 1 (AUTSX1) [MIM:300425]. AUTSX1 is a pervasive CC developmental disorder (PDD), prototypically characterized by CC impairments in reciprocal social interaction and communication, CC restricted and stereotyped patterns of interests and activities, CC and the presence of developmental abnormalities by 3 years of age. CC -!- DISEASE: Defects in NLGN3 may be the cause of susceptibility to X- CC linked Asperger syndrome 1 (ASPGX1) [MIM:300494]. ASPGX1 is CC considered to be a form of childhood autism. CC -!- SIMILARITY: Belongs to the type-B carboxylesterase/lipase family. CC -!- SEQUENCE CAUTION: CC Sequence=AAF71231.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence; CC -!- WEB RESOURCE: Name=GeneReviews; CC URL="http://www.genetests.org/query?gene=NLGN3"; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF217411; AAF71230.1; -; mRNA. DR EMBL; AF217412; AAF71231.1; ALT_SEQ; mRNA. DR EMBL; AF217413; AAF71232.1; -; Genomic_DNA. DR EMBL; AF217413; AAF71233.1; -; Genomic_DNA. DR EMBL; AB040913; BAA96004.1; ALT_INIT; mRNA. DR EMBL; AK074814; BAC11226.1; ALT_INIT; mRNA. DR UniGene; Hs.438877; -. DR HSSP; P19835; 1JMY. DR MEROPS; S09.987; -. DR PhosphoSite; Q9NZ94; -. DR Ensembl; ENSG00000196338; Homo sapiens. DR H-InvDB; HIX0016859; -. DR HGNC; HGNC:14289; NLGN3. DR HPA; HPA003183; -. DR MIM; 300336; gene. DR MIM; 300425; phenotype. DR MIM; 300494; phenotype. DR Orphanet; 1162; Asperger syndrome. DR Orphanet; 106; Autism. DR PharmGKB; PA31649; -. DR HOGENOM; Q9NZ94; -. DR HOVERGEN; Q9NZ94; -. DR LinkHub; Q9NZ94; -. DR ArrayExpress; Q9NZ94; -. DR CleanEx; HS_NLGN3; -. DR GermOnline; ENSG00000196338; Homo sapiens. DR GO; GO:0009986; C:cell surface; IDA:UniProtKB. DR GO; GO:0045202; C:synapse; ISS:UniProtKB. DR GO; GO:0005515; F:protein binding; IPI:UniProtKB. DR GO; GO:0035176; P:social behavior; IMP:UniProtKB. DR GO; GO:0050808; P:synapse organization and biogenesis; IMP:UniProtKB. DR InterPro; IPR002018; CarbesteraseB. DR InterPro; IPR000460; Neuroligin. DR PANTHER; PTHR11559; CarbesteraseB; 1. DR Pfam; PF00135; COesterase; 1. DR PRINTS; PR01090; NEUROLIGIN. DR PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1. PE 1: Evidence at protein level; KW Alternative splicing; Cell adhesion; Disease mutation; Glycoprotein; KW Membrane; Phosphoprotein; Signal; Transmembrane. FT SIGNAL 1 37 Potential. FT CHAIN 38 848 Neuroligin-3. FT /FTId=PRO_0000008645. FT TOPO_DOM 38 709 Extracellular (Potential). FT TRANSMEM 710 730 Potential. FT TOPO_DOM 731 848 Cytoplasmic (Potential). FT MOD_RES 792 792 Phosphotyrosine (By similarity). FT CARBOHYD 98 98 N-linked (GlcNAc...) (Potential). FT CARBOHYD 545 545 N-linked (GlcNAc...) (Potential). FT DISULFID 106 141 By similarity. FT DISULFID 340 351 By similarity. FT DISULFID 510 544 By similarity. FT VAR_SEQ 153 172 Missing (in isoform 2). FT /FTId=VSP_007534. FT VARIANT 451 451 R -> C (in AUTSX1 and ASPGX1). FT /FTId=VAR_015668. FT CONFLICT 224 224 L -> P (in Ref. 1; AAF71230). SQ SEQUENCE 848 AA; 93895 MW; B3EE2FAB7E427C82 CRC64; MWLRLGPPSL SLSPKPTVGR SLCLTLWFLS LALRASTQAP APTVNTHFGK LRGARVPLPS EILGPVDQYL GVPYAAPPIG EKRFLPPEPP PSWSGIRNAT HFPPVCPQNI HTAVPEVMLP VWFTANLDIV ATYIQEPNED CLYLNVYVPT EDVKRISKEC ARKPNKKICR KGGSGAKKQG EDLADNDGDE DEDIRDSGAK PVMVYIHGGS YMEGTGNMID GSILASYGNV IVITLNYRVG VLGFLSTGDQ AAKGNYGLLD QIQALRWVSE NIAFFGGDPR RITVFGSGIG ASCVSLLTLS HHSEGLFQRA IIQSGSALSS WAVNYQPVKY TSLLADKVGC NVLDTVDMVD CLRQKSAKEL VEQDIQPARY HVAFGPVIDG DVIPDDPEIL MEQGEFLNYD IMLGVNQGEG LKFVEGVVDP EDGVSGTDFD YSVSNFVDNL YGYPEGKDTL RETIKFMYTD WADRDNPETR RKTLVALFTD HQWVEPSVVT ADLHARYGSP TYFYAFYHHC QSLMKPAWSD AAHGDEVPYV FGVPMVGPTD LFPCNFSKND VMLSAVVMTY WTNFAKTGDP NKPVPQDTKF IHTKANRFEE VAWSKYNPRD QLYLHIGLKP RVRDHYRATK VAFWKHLVPH LYNLHDMFHY TSTTTKVPPP DTTHSSHITR RPNGKTWSTK RPAISPAYSN ENAQGSWNGD QDAGPLLVEN PRDYSTELSV TIAVGASLLF LNVLAFAALY YRKDKRRQEP LRQPSPQRGA GAPELGAAPE EELAALQLGP THHECEAGPP HDTLRLTALP DYTLTLRRSP DDIPLMTPNT ITMIPNSLVG LQTLHPYNTF AAGFNSTGLP HSHSTTRV //